Rapid Capture System
- UID
- IMP/IVD/2022/000384_5d9bf2f5bf6b307bda8f672d733a8f53_499dcc694e3a7f6cd71a795e7ffac233
- Device class
- Class A
- Brand name
- Rapid Capture System
- License holder
- QIAGEN India Pvt. Ltd
- Approving authority
- CDSCO
- Product information
- The RCS is a general use automated pipetting and dilution system that can be used with approved or cleared digene HC2 DNA tests for high-volume sample-throughput testing. User intervention is limited to sample preparation, RCS deck setup, loading of specimen racks onto the RCS deck and chemiluminescent signal detection and result reporting.
Rapid Capture System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000384_5d9bf2f5bf6b307bda8f672d733a8f53_499dcc694e3a7f6cd71a795e7ffac233. This device is marketed under the brand name Rapid Capture System. The license holder is QIAGEN India Pvt. Ltd, and it is classified as Device Class Class A. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.